GDXD | SCO | GDXD / SCO | |
Gain YTD | -95.791 | 15.898 | -603% |
Net Assets | 39.4M | 91.3M | 43% |
Total Expense Ratio | 0.95 | 0.95 | 100% |
Turnover | N/A | N/A | - |
Yield | 0.00 | 0.00 | - |
Fund Existence | 5 years | 17 years | - |
GDXD | SCO | |
---|---|---|
RSI ODDS (%) | 3 days ago90% | 3 days ago90% |
Stochastic ODDS (%) | 3 days ago90% | 3 days ago90% |
Momentum ODDS (%) | N/A | 3 days ago90% |
MACD ODDS (%) | N/A | 3 days ago90% |
TrendWeek ODDS (%) | 3 days ago90% | 3 days ago88% |
TrendMonth ODDS (%) | 3 days ago90% | 3 days ago90% |
Advances ODDS (%) | N/A | 9 days ago87% |
Declines ODDS (%) | 3 days ago90% | 11 days ago90% |
BollingerBands ODDS (%) | 3 days ago86% | 3 days ago90% |
Aroon ODDS (%) | 3 days ago90% | N/A |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SBHIX | 24.50 | 0.23 | +0.95% |
Saratoga Health & Biotechnology I | |||
JEPRX | 14.12 | 0.08 | +0.57% |
JPMorgan Equity Premium Income R6 | |||
RPMAX | 16.32 | 0.08 | +0.49% |
Reinhart Genesis PMV Investor | |||
MSCGX | 11.61 | 0.05 | +0.43% |
Mercer US Small/Mid Cap Equity Y3 | |||
GINUX | 31.63 | -0.34 | -1.06% |
Goldman Sachs Small Cap Gr Insghts R6 |